Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hansson

Showing results (31-40 of 670) with videos related to

Pageof 67
Sort By:
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Should a modern antihypertensive drug possess cardioprotective properties?L Hansson
Blood Pressure. Supplement|January 1, 1997
Evaluation of endpoints in hypertensionL Hansson
European Heart Journal|August 1, 1997
ACE inhibition and left ventricular remodellingL Hansson
Drugs|January 1, 1990
Isradipine in hypertensionL Hansson
Lakartidningen|November 26, 1980
[Keep the mm Hg as a blood pressure measure. Too many disadvantages in making the change to kPa]L Hansson
Blood Pressure. Supplement|January 1, 1995
Status of current therapies for hypertensionL Hansson
Cardiology|January 1, 1997
Issues in the treatment of hypertension: current and future perspectivesL Hansson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1996
Hypertension in the elderlyL Hansson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
The optimal blood pressure reductionL Hansson
American Journal of Hypertension|October 1, 1995
Cardioprotective potential of antihypertensivesL Hansson
Pageof 67

Showing results (31-40 of 670) with videos related to

Sort By:
Pageof 67
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|March 3, 1998
Should a modern antihypertensive drug possess cardioprotective properties?L Hansson
Blood Pressure. Supplement|January 1, 1997
Evaluation of endpoints in hypertensionL Hansson
European Heart Journal|August 1, 1997
ACE inhibition and left ventricular remodellingL Hansson
Drugs|January 1, 1990
Isradipine in hypertensionL Hansson
Lakartidningen|November 26, 1980
[Keep the mm Hg as a blood pressure measure. Too many disadvantages in making the change to kPa]L Hansson
Blood Pressure. Supplement|January 1, 1995
Status of current therapies for hypertensionL Hansson
Cardiology|January 1, 1997
Issues in the treatment of hypertension: current and future perspectivesL Hansson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|October 1, 1996
Hypertension in the elderlyL Hansson
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|September 1, 1996
The optimal blood pressure reductionL Hansson
American Journal of Hypertension|October 1, 1995
Cardioprotective potential of antihypertensivesL Hansson
Pageof 67